Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)

Clinical trial NCT06032000 · COMPLETED

Trial details

NCT number: NCT06032000
Sponsor: Lemonex
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

COVID-19 Infection COVID-19 Vaccine Adverse Reaction

Start date: 2023-11-06
Primary completion: 2025-03-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.